NASHVILLE, Tenn., Oct. 02, 2017 -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced that it intends to redeem $100.0 million of its $400.0 million outstanding 5.75% Senior Notes due 2021 (the “Notes”) in accordance with the terms of the indenture governing the Notes. The Company intends to use net proceeds from the issuance of 8.3 million shares of common stock on August 14, 2017 and borrowings under its unsecured revolving credit facility to fund the redemption. The Company expects to record a charge in the fourth quarter of 2017 of approximately $12.2 million for early extinguishment of debt, which includes approximately $0.5 million of unamortized costs and discounts.
The Company will redeem the $100.0 million portion of the Notes on November 1, 2017 (the “Redemption Date”) at a redemption price equal to an aggregate of $113.4 million, consisting of: a) $100.0 million in outstanding principal; b) $1.7 million in interest accrued but not yet paid as of the Redemption Date; and c) a “make-whole amount” of $11.7 million in accordance with the indenture.
The redemption price for the redeemed Notes and accrued interest will become due and payable on the Redemption Date. Following that date, interest will cease to accrue and be payable on the redeemed Notes and the redeemed Notes will be cancelled. Payment of the redemption price will be made only upon presentation and surrender of the redeemed Notes in the manner specified in the notice of redemption, which is being provided to registered holders of the Notes by Branch Banking and Trust Company (“BB&T”), as trustee for the Notes. Copies of the applicable notice of redemption for the redeemed Notes may be obtained from BB&T by calling its Corporate Trust Department at (252) 246-4679.
Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of June 30, 2017, the Company had gross investments of approximately $3.6 billion in 197 real estate properties in 26 states totaling approximately 14.5 million square feet. The Company provided leasing and property management services to approximately 10.9 million square feet nationwide.
In addition to the historical information contained within, the matters discussed in this press release may contain forward-looking statements that involve risks and uncertainties, including the use of proceeds from the note offering. These risks are discussed in filings with the Securities and Exchange Commission by Healthcare Realty Trust, including its Annual Report on Form 10-K for the year ended December 31, 2016 under the heading “Risk Factors.” Forward-looking statements represent the Company's judgment as of the date of this release. The Company disclaims any obligation to update forward-looking material.
Carla Baca
Director of Corporate Communications
P: 615.269.8175


Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 



